2025 Annual Meeting | C73 - Low and High Pressure Headache: Clinical Presentation and Approach to Evaluation and Management

Date Sunday 04/06/25

Time 03:30 PM - 05:30 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Kerry L. Knievel, DO

Topic(s) Headache

Learning Objectives 1. Describe clinical features,evaluation/clinical treatment approachof CSF leak. Identify the symptoms in patients with refractory orthostatic new daily persistent headache.
2. Describe the clinical features, evaluation/clinical treatment approach for IIH.
3. Describe the interventional radiology evaluation for idetification of CSF leak and how to employ treatment options to various leak types.
4. Identify IIH patients who qualify for detailed venous evaluation.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic

Event Timeline
No timeline events available at this time.

Faculty Disclosures
Kerry L. Knievel, DO	Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Knievel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . The institution of Dr. Knievel has received research support from Abbvie .
Wouter Schievink, MD	Dr. Schievink has nothing to disclose.